Verition Fund Management LLC lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 60.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,634 shares of the company's stock after selling 29,538 shares during the period. Verition Fund Management LLC's holdings in Option Care Health were worth $615,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Westfield Capital Management Co. LP lifted its stake in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after purchasing an additional 599,589 shares during the last quarter. Global Alpha Capital Management Ltd. lifted its position in shares of Option Care Health by 108.3% during the third quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company's stock valued at $1,559,000 after buying an additional 25,905 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock valued at $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Edgestream Partners L.P. grew its position in shares of Option Care Health by 96.8% in the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company's stock worth $9,736,000 after buying an additional 172,845 shares during the last quarter. Finally, Geneva Capital Management LLC purchased a new position in shares of Option Care Health in the 3rd quarter worth approximately $24,679,000. Institutional investors own 98.05% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently commented on OPCH shares. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. JMP Securities raised their price target on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a report on Monday, September 30th. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. Barrington Research decreased their price objective on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Finally, Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $30.14.
Check Out Our Latest Stock Report on Option Care Health
Insider Buying and Selling at Option Care Health
In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.64% of the company's stock.
Option Care Health Stock Performance
OPCH traded down $0.20 during trading on Wednesday, reaching $23.66. 1,946,447 shares of the company's stock were exchanged, compared to its average volume of 1,564,618. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company's fifty day simple moving average is $25.76 and its 200-day simple moving average is $28.58. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63. The stock has a market capitalization of $4.03 billion, a P/E ratio of 20.05, a price-to-earnings-growth ratio of 2.37 and a beta of 1.33.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
